SUBSCRIBE
SUBSCRIBE

Elios Therapeutics, LLC

NEWS
Job Trends
BioSpace Movers and Shakers: Ambys, Decibel, Verona, and More
Biotech and pharma companies tap new members of executive leadership teams and boards.
June 27, 2019
 · 
6 min read
 · 
Alex Keown
IN THE PRESS
Business
Elios Therapeutics Announces the Appointment of Mark H.N. Corrigan, M.D. as Chairman of the Board of Directors
February 10, 2022
 · 
3 min read
Business
Elios Therapeutics Strengthens Board of Directors with Appointment of Key Financial Executive Michael Caprio
September 29, 2021
 · 
5 min read
Drug Development
Elios Therapeutics Personalized Cancer Vaccine Demonstrates Long-Term Survival Benefit Among High-Risk Melanoma Patients in Phase IIb Final Analysis
August 5, 2020
 · 
9 min read
Drug Development
Elios Therapeutics Presents New Phase IIb Data for Personalized Cancer Vaccine in High-Risk Melanoma Patients at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium
February 7, 2020
 · 
9 min read
Drug Development
Elios Therapeutics Presents Primary Analysis of Phase IIb Study Showing Personalized Cancer Vaccine Significantly Reduces Risk of Melanoma Recurrence in High-Risk Patients
November 21, 2019
 · 
9 min read
Drug Development
Elios Therapeutics Announces Positive Top-Line Data from Phase IIb Study Evaluating TLPLDC, a Personalized Therapeutic Cancer Vaccine, in Patients with High-Risk Melanoma
July 17, 2019
 · 
8 min read
Business
Elios Therapeutics Announces Appointment of Phillip Johnson as Chief Financial Officer
June 26, 2019
 · 
6 min read
Drug Development
Elios Therapeutics Announces Interim Phase IIb Results of TLPLDC, a Personalized Therapeutic Cancer Vaccine for the Treatment of Melanoma, at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
June 1, 2018
 · 
6 min read
Drug Development
Elios Therapeutics, LLC Release: Novel Cancer Vaccine In Combination With Check Point Blockades Holds Promise
February 5, 2016
 · 
3 min read
JOBS